The therapy cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed.
Merck & Co scrapped a late-stage trial of a combination therapy with its cancer drug Keytruda as interim data showed it was unlikely to meet the main goals.
US Senator Elizabeth Warren has sent the nation s top patent regulator a letter urging close scrutiny of Merck s requests for new patents on its blockbuster cancer treatment Keytruda, saying further efforts to protect the drug could be an abuse of the system.
A recent rise in the number of men diagnosed with prostate cancer has fanned resentment among patient advocates, who say their concerns have gone unheeded.
In cancer patients with brain metastases, preoperative stereotactic radiotherapy is associated with improved outcomes compared to no SRT, a small trial shows.